BLCO
Price
$17.44
Change
+$0.26 (+1.51%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
6.14B
6 days until earnings call
Intraday BUY SELL Signals
COO
Price
$61.64
Change
+$2.67 (+4.53%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
11.21B
42 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BLCO vs COO

BLCO vs COO Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BLCO vs. COO commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLCO is a StrongBuy and COO is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BLCO with price predictions
Oct 21, 2026

BLCO in upward trend: price rose above 50-day moving average on October 21, 2026

BLCO moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend. In 35 of 45 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 78%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BLCO's RSI Oscillator exited the oversold zone, 19 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.

The Moving Average Convergence Divergence (MACD) for BLCO just turned positive on October 21, 2026. Looking at past instances where BLCO's MACD turned positive, the stock continued to rise in 29 of 49 cases over the following month. The odds of a continued upward trend are 59%.

Following a +3.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where BLCO advanced for three days, in 159 of 242 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

BLCO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BLCO as a result. In 62 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 67%.

The 10-day moving average for BLCO crossed bearishly below the 50-day moving average on September 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 62%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BLCO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

The Aroon Indicator for BLCO entered a downward trend on October 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.962) is normal, around the industry mean (4.952). P/E Ratio (-35.792) is within average values for comparable stocks, (36.644). Projected Growth (PEG Ratio) (0.888) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (1.139) is also within normal values, averaging (56.876).

The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. BLCO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 48 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BLCO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for COO with price predictions
Oct 21, 2026

COO's RSI Indicator recovers from oversold territory

The RSI Indicator for COO moved out of oversold territory on October 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 36 similar instances when the indicator left oversold territory. In 26 of the 36 cases the stock moved higher. This puts the odds of a move higher at 72%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 16, 2026. You may want to consider a long position or call options on COO as a result. In 55 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.

The Moving Average Convergence Divergence (MACD) for COO just turned positive on September 25, 2026. Looking at past instances where COO's MACD turned positive, the stock continued to rise in 23 of 41 cases over the following month. The odds of a continued upward trend are 56%.

Following a +2.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where COO advanced for three days, in 152 of 271 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.

The Aroon Indicator entered an Uptrend today. In 115 of 222 cases where COO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 52%.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 57 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.346) is normal, around the industry mean (4.952). P/E Ratio (20.126) is within average values for comparable stocks, (36.644). Projected Growth (PEG Ratio) (0.532) is also within normal values, averaging (4.143). Dividend Yield (0.001) settles around the average of (0.005) among similar stocks. P/S Ratio (2.526) is also within normal values, averaging (56.876).

The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. COO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 86 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. COO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
COO: Fundamental Ratings
COO
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
80
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
86
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BLCOCOO
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
58%
Momentum
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
61%
MACD
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
56%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
52%
Advances
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 3 days ago
56%
Declines
ODDS (%)
Bearish Trend 10 days ago
67%
Bearish Trend 15 days ago
60%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
70%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
52%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (BLCO: $17.18 vs. COO: $58.97)
Brand notoriety: BLCO and COO are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BLCO: 93% vs. COO: 61%
Market capitalization -- BLCO: $6.14B vs. COO: $11.72B
BLCO [@Pharmaceuticals: Other] is valued at $6.14B. COO’s [@Pharmaceuticals: Other] market capitalization is $11.72B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $156.8B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLCO’s FA Score shows that 1 FA rating(s) are green while COO’s FA Score has 0 green FA rating(s).

  • BLCO’s FA Score: 1 green, 4 red.
  • COO’s FA Score: 0 green, 5 red.
According to our system of comparison, BLCO is a better buy in the long-term than COO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLCO’s TA Score shows that 5 TA indicator(s) are bullish while COO’s TA Score has 5 bullish TA indicator(s).

  • BLCO’s TA Score: 5 bullish, 5 bearish.
  • COO’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, COO is a better buy in the short-term than BLCO.

Price Growth

BLCO (@Pharmaceuticals: Other) experienced а +7.11% price change this week, while COO (@Pharmaceuticals: Other) price change was +7.45% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.74%. For the same industry, the average monthly price growth was -3.62%, and the average quarterly price growth was +9.09%.

Reported Earning Dates

BLCO is expected to report earnings on Oct 28, 2026.

COO is expected to report earnings on Dec 03, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+0.74% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
BLCO
Daily Signal:
Gain/Loss:
COO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

BLCO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLCO has been loosely correlated with ICUI. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BLCO jumps, then ICUI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLCO
1D Price
Change %
BLCO100%
+1.48%
ICUI - BLCO
48%
Loosely correlated
-0.15%
COO - BLCO
45%
Loosely correlated
-0.25%
CRL - BLCO
45%
Loosely correlated
+9.33%
MTD - BLCO
44%
Loosely correlated
+2.69%
RVTY - BLCO
44%
Loosely correlated
+0.38%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BEX25.843.24
+14.34%
Tradr 2X Long BE Daily ETF (BEX)
ANEL21.970.66
+3.08%
Defiance Daily Target 2x Long ANET ETF (ANEL)
HEFA46.610.17
+0.37%
iShares Currency Hedged MSCI EAFE ETF (HEFA)
IWMW37.050.11
+0.29%
iShares Russell 2000 BuyWrite ETF (IWMW)
FSMB19.62-0.04
-0.20%
First Trust Short Duration Managed Municipal ETF (FSMB)